Table 3 Agreement of patient- and proxy-ratings for the EORTC QLQ-BN20
From: Do neurooncological patients and their significant others agree on quality of life ratings?
EORTC QLQ-BN20 | Patient Mean (SD) | Proxy Mean (SD) | Patient minus Proxy | effect size | t-value p-value | Pearson-Correlation (CI95%) | agreement (+/- 5 point) |
|---|---|---|---|---|---|---|---|
Future Uncertainty | 28.3 (29.6) | 31.1 (28.1) | -2.8 | -0.10 | t = -0.67; p = 0.51 | 0.55* (0.29-0.74) | 29% |
Visual Disorders | 13.3 (16.5) | 12.9 (19.9) | 0.4 | 0.02 | t = 0.16; p = 0.88 | 0.58* (0.34-0.76) | 50% |
Motor Dysfunction | 21.1 (25.9) | 21.8 (28.3) | -0.7 | -0.02 | t = -0.20; p = 0.84 | 0.67* (0.46-0.81) | 44% |
Communication Deficits | 26.3 (28.1) | 23.8 (33.4) | 2.5 | 0.08 | t = 0.64; p = 0.53 | 0.67* (0.46-0.81) | 45% |
Headaches | 34.1 (35.7) | 32.5 (34.9) | 1.6 | 0.04 | t = 0.32; p = 0.75 | 0.59* (0.35-0.77) | 57% |
Seizures | 13.5 (30.4) | 7.1 (17.3) | 6.3 | 0.27 | t = 1.43; p = 0.16 | 0.38* (0.09-0.62) | 81% |
Drowsiness | 38.9 (32.9) | 36.5 (30.2) | 2.4 | 0.08 | t = 0.45; p = 0.65 | 0.42* (0.13-0.65) | 38% |
Hair Loss | 9.2 (18.5) | 7.5 (19.2) | 1.7 | 0.09 | t = 0.57; p = 0.57 | 0.52* (0.26-0.72) | 78% |
Itchy Skin | 12.8 (22.4) | 14.5 (29.4) | -1.7 | -0.07 | t = -0.37; p = 0.71 | 0.42* (0.13-0.65) | 64% |
Weakness of Legs | 25.0 (36.8) | 21.7 (31.6) | 3.3 | 0.10 | t = 0.58; p = 0.56 | 0.45* (0.17-0.66) | 60% |
Bladder Control | 10.0 (21.6) | 6.7 (15.5) | 3.3 | 0.18 | t = 0.85; p = 0.40 | 0.14 (-0.17-0.43) | 75% |